deltatrials
Completed OBSERVATIONAL NCT04004351

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma (PROTECT)

Modalités de Prise en chaRge en Pratique quOTidienne d'Allergologie Des Enfants et/ou adolesCents souffranT d'Allergie Aux Acariens / Treatment Modalities in Allergist Daily Practice in Children and/or Adolescents Suffering From HDM Allergy

Sponsor: Monitoring Force Group

Conditions Allergy
Updated 4 times since 2019 Last updated: Jul 2, 2019 Started: Sep 16, 2013 Primary completion: Jul 12, 2016 Completion: Jul 12, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04004351, this observational or N/A phase trial focuses on Allergy and remains completed. Sponsored by Monitoring Force Group, it has been updated 4 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Aug 2019 — Jan 2021 [monthly]

    Completed

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Monitoring Force Group
  • Stallergenes Greer
Data source: Stallergenes Greer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.